These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 713456

  • 1. [New differential diagnostic and therapeutic possibilities in arterial hypertension].
    Gogin EE, Gerasimov GM, Martyniuk AD.
    Klin Med (Mosk); 1978 Oct; 56(10):30-5. PubMed ID: 713456
    [No Abstract] [Full Text] [Related]

  • 2. [Diagnosis and therapy of arterial hypertension. Significance of the renin-angiotensin-aldosterone system in differential diagnosis and therapy].
    Nast HP, Philipp T.
    Fortschr Med; 1974 Apr 18; 92(11):447-51. PubMed ID: 4362672
    [No Abstract] [Full Text] [Related]

  • 3. [Plasma renin activity, plasma aldosterone concentration in the differential diagnosis of curable forms of secondary hypertension].
    Liu LS.
    Zhonghua Nei Ke Za Zhi; 1985 Jan 18; 24(1):3-6, 61. PubMed ID: 3884292
    [No Abstract] [Full Text] [Related]

  • 4. [Diagnostic value of the captopril test in patients with arterial hypertension].
    Kuska J, Kokot F, Nowicki M, Marcinkowski W, Koziak M, Fojt T.
    Kardiol Pol; 1989 Jan 18; 32(3):131-7. PubMed ID: 2695683
    [Abstract] [Full Text] [Related]

  • 5. [Effect of guanabenz on arterial pressure and the renin-aldosterone system in hypertensive patients].
    Rappelli A, Glorioso N, Tedde R, Madeddu P, Dessì Fulgheri P, Campus S.
    Boll Soc Ital Cardiol; 1978 Jan 18; 23(1):177-83. PubMed ID: 754771
    [No Abstract] [Full Text] [Related]

  • 6. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S, Nakahama H, Kamide K, Fukuchi K, Iwanaga Y, Nakata H, Yoshihara F, Horio T, Nakamura S, Kawano Y.
    Clin Exp Hypertens; 2008 Oct 18; 30(7):640-7. PubMed ID: 18855267
    [Abstract] [Full Text] [Related]

  • 7. [What tests should be conducted for secondary arterial hypertension in hypertensive patients resistant to treatment?].
    Denolle T, Hanon O, Mounier-Vehier C, Marquand A, Fauvel JP, Laurent P, Tison E, Equine O, Ducloux D, Girerd X.
    Arch Mal Coeur Vaiss; 2000 Aug 18; 93(8):1037-9. PubMed ID: 10989753
    [Abstract] [Full Text] [Related]

  • 8. Screening, diagnosis, and treatment of secondary hypertension.
    Weinberger MH.
    Compr Ther; 1984 May 18; 10(5):64-9. PubMed ID: 6734128
    [No Abstract] [Full Text] [Related]

  • 9. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET, Stinson J, Ramirez G.
    Postgrad Med; 1980 Oct 18; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [Abstract] [Full Text] [Related]

  • 10. [Proteinuria as indication for antihypertensive drugs. The kidney--cause and victim of arterial hypertension].
    MMW Fortschr Med; 2002 Dec 12; 144(50):53. PubMed ID: 14610867
    [No Abstract] [Full Text] [Related]

  • 11. Antihypertensive and aldosterone-lowering effects of synthetic atrial natriuretic factor in renin-dependent renovascular hypertension.
    Volpe M, Odell G, Kleinert HD, Camargot MJ, Laragh JH, Lewicki JA, Maack T, Vaughan ED, Atlas SA.
    J Hypertens Suppl; 1984 Dec 12; 2(3):S313-5. PubMed ID: 6242558
    [Abstract] [Full Text] [Related]

  • 12. [Arterial hypertension with hypokalemia].
    Montanari G, Zanaletti F, Quadrelli GC, Di Battista F, Ongis GA, Fraschini A, Zinzalini G, Abbiati C.
    Minerva Med; 1988 Mar 12; 79(3):209-14. PubMed ID: 2966307
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of arterial hypertension patients depending on renin activity].
    Naugol'nova SB, Lapshina LA.
    Vrach Delo; 1984 Feb 12; (2):61-5. PubMed ID: 6372240
    [No Abstract] [Full Text] [Related]

  • 14. [Antihypertensive effects of coenzyme Q10 in essential hypertension--in relation to the renin-aldosterone system].
    Hata S, Kunida H, Oyama Y.
    Horumon To Rinsho; 1977 Sep 12; 25(9):1019-23. PubMed ID: 923110
    [No Abstract] [Full Text] [Related]

  • 15. [Differential diagnosis and therapy of essential hypertension].
    Spieker C, Barenbrock M, Rahn KH.
    Z Arztl Fortbild (Jena); 1996 May 12; 90(3):213-20. PubMed ID: 8779234
    [Abstract] [Full Text] [Related]

  • 16. Effect of enalapril on renin, angiotensin converting enzyme activity, aldosterone and prostaglandins in patients with hypertension.
    Larochelle P, Gutkowska J, Schiffrin E, Kuchel O, Hamet P, Genest J.
    Clin Invest Med; 1985 May 12; 8(3):197-201. PubMed ID: 2994932
    [Abstract] [Full Text] [Related]

  • 17. [Significance of the saralasin infusion test in the diagnosis of arterial hypertension].
    Glorioso N, Madeddu P, Dessì-Fulgheri P, Meloni F, Palermo M, Fiori C, Rappelli A.
    Boll Soc Ital Cardiol; 1980 May 12; 25(9):1035-46. PubMed ID: 7025868
    [No Abstract] [Full Text] [Related]

  • 18. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A, Mahgoub M, Hall M, Feely J.
    Am J Hypertens; 2005 Dec 12; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive effect of a new calcium channel blocker, FK 235, in essential hypertension.
    Mizuno K, Hashimoto S, Yabe R, Kunii N, Niimura S, Tani M, Watari H, Fukuchi S.
    Res Commun Chem Pathol Pharmacol; 1986 Apr 12; 52(1):3-15. PubMed ID: 3520729
    [Abstract] [Full Text] [Related]

  • 20. [Hypertension].
    Steiner A, Hermann A, Vetter W.
    Schweiz Rundsch Med Prax; 1989 Jan 17; 78(3):43-5. PubMed ID: 2919254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.